Delivery Order SPE2DB22D2005-SPE2DB26FJFA8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,537.17 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under...
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $2,225.01 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injections on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December...
- The Defense Logistics Agency awarded a $6,048.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections, valued at $2,720.90 with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025, issued on September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,088.36 for Mounjaro 15 mg/0.5 mL pen injections on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at approximately $1...
- The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 27, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $6,802.25 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJFA8Delivery Order
The Defense Logistics Agency awarded a $6,108.09 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a completion date of November 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, fulfills the place of performance requirement at its corporate office location. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The Mounjaro delivery order reflects the contractor's role in supporting the Defense Health Agency and other federal healthcare systems through the flexible pharmaceutical prime vendor contract vehicle, enabling efficient procurement of diabetes and endocrinology medications for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 10/31/25 |